Skip to main content
Livermore
Livermore
ZHEN

StemPoint Capital LP

SEC CIK
0001952142
Latest filing
Aug 14, 2026

Holdings in Q3 2024

Holdings as of Sep 30, 2024, filed Nov 13, 2024. Long positions only; changes compare share counts with Q2 2024.

Institution overview
Positions
50
+8 vs. Q2 2024
Portfolio value
$333.4M
−$6.49M (−1.9%) vs. Q2 2024
Filed
Nov 13, 2024
SEC
Holdings of StemPoint Capital LP in Q3 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
SNDXSyndax Pharmaceuticals IncCOM1,731,191$33.3M10.0%+319,015+22.6%AddedHistory
ROIVRoivant Sciences Ltd.SHS2,769,819$32.0M9.6%+57,078+2.1%AddedHistory
MRUSMerus N.V.COM421,222$21.0M6.3%+132,554+45.9%AddedHistory
IMVTImmunovant, Inc.COM671,001$19.1M5.7%−340,878−33.7%ReducedHistory
ARQTArcutis Biotherapeutics, Inc.COM1,778,318$16.5M5.0%+812,926+84.2%AddedHistory
FOLDAmicus Therapeutics, Inc.COM1,481,809$15.8M4.7%−13,238−0.9%ReducedHistory
BMYBristol Myers Squibb CoStock275,303$14.2M4.3%+275,303NewHistory
APLTApplied Therapeutics, Inc.COM1,554,586$13.2M4.0%−656,734−29.7%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM213,815$10.9M3.3%−337,280−61.2%ReducedHistory
BHVNBiohaven Ltd.COM216,440$10.8M3.2%−16,815−7.2%ReducedHistory
PRAXPraxis Precision Medicines, Inc.COM NEW174,034$10.0M3.0%+144,775+494.8%AddedHistory
AUTLAutolus Therapeutics plcSPON ADS2,616,602$9.50M2.8%−46,130−1.7%ReducedHistory
INCYIncyte CorpCOM129,490$8.56M2.6%+129,490NewHistory
DNLIDenali Therapeutics Inc.COM282,050$8.22M2.5%+31,040+12.4%AddedHistory
DAWNDay One Biopharmaceuticals, Inc.Stock506,978$7.06M2.1%+506,978NewHistory
SLRNACELYRIN, Inc.COM1,317,854$6.50M1.9%+1,317,854NewHistory
SLNOSoleno Therapeutics IncCOM123,177$6.22M1.9%+123,177NewHistory
CABACabaletta Bio, Inc.COM1,278,444$6.03M1.8%+100,339+8.5%AddedHistory
IMTXImmatics N.V.SHS449,735$5.13M1.5%−52,472−10.4%ReducedHistory
KROSKeros Therapeutics, Inc.COM86,930$5.05M1.5%+86,930NewHistory
ACLXArcellx, Inc.COMMON STOCK60,076$5.02M1.5%−220,633−78.6%ReducedHistory
VTGNVistagen Therapeutics, Inc.COM1,846,792$4.90M1.5%−1,790−0.1%ReducedHistory
NRIXNurix Therapeutics, Inc.COM203,015$4.56M1.4%−258−0.1%ReducedHistory
TCRXTScan Therapeutics, Inc.COM860,951$4.29M1.3%+15,882+1.9%AddedHistory
ZURAZura Bio LtdCLASS A ORD SHS1,044,168$4.24M1.3%+1,044,168NewHistory
IDYAIDEAYA Biosciences, Inc.COM132,703$4.20M1.3%+30,916+30.4%AddedHistory
TERNTerns Pharmaceuticals, Inc.COM449,321$3.75M1.1%+449,321NewHistory
CATXPerspective Therapeutics, Inc.COM NEW238,084$3.18M1.0%−105,726−30.8%ReducedHistory
PYXSPyxis Oncology, Inc.COMMON STOCK850,210$3.12M0.9%−352,465−29.3%ReducedHistory
NGNENeurogene Inc.COM73,299$3.08M0.9%−5,302−6.7%ReducedHistory
URGNUroGen Pharma Ltd.COM241,984$3.07M0.9%+241,984NewHistory
VIGLVigil Neuroscience, Inc.COM743,719$2.53M0.8%−693−0.1%ReducedHistory
WVEWave Life Sciences, Inc.SHS300,000$2.46M0.7%+300,000NewHistory
BBIOBridgeBio Pharma, Inc.COM94,885$2.42M0.7%+94,885NewHistory
JANXJanux Therapeutics, Inc.COM49,415$2.24M0.7%−43,534−46.8%ReducedHistory
SRZNSurrozen, Inc.COM NEW182,918$2.19M0.7%+39,408+27.5%AddedHistory
RYTMRhythm Pharmaceuticals, Inc.COM41,268$2.16M0.6%+41,268NewHistory
BBOTBridgeBio Oncology Therapeutics, Inc.CL A ORD SHS200,000$2.09M0.6%00.0%UnchangedHistory
SRPTSarepta Therapeutics, Inc.COM15,014$1.88M0.6%+15,014NewHistory
TARAProtara Therapeutics, Inc.COM STK942,857$1.73M0.5%−41,256−4.2%ReducedHistory
FRNMFreenome, Inc.CL A ORD SHS150,000$1.50M0.5%00.0%UnchangedHistory
TRMLTourmaline Bio, Inc.COM55,523$1.43M0.4%+55,523NewHistory
CAPRCapricor Therapeutics, Inc.COM NEW93,638$1.42M0.4%+93,638NewHistory
ALKSAlkermes plc.SHS48,918$1.37M0.4%+48,918NewHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS83,662$1.34M0.4%+83,662NewHistory
MBXMBX Biosciences, Inc.COM50,000$1.30M0.4%+50,000NewHistory
CYTKCytokinetics IncCOM NEW14,464$763.7K0.2%+14,464NewHistory
RVMDRevolution Medicines, Inc.COM16,654$755.3K0.2%+16,654NewHistory
ATXSAstria Therapeutics, Inc.COM56,287$618.9K0.2%+56,287NewHistory
EWTXEdgewise Therapeutics, Inc.COM19,900$531.1K0.2%−251,157−92.7%ReducedHistory

Options (4)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of StemPoint Capital LP in Q3 2024
SecurityClassPutsCalls
SNDXSyndax Pharmaceuticals IncCOM–$381.8K
IMVTImmunovant, Inc.COM–$112.5K
APLTApplied Therapeutics, Inc.COM–$75.5K
ARQTArcutis Biotherapeutics, Inc.COM–$12.5K

Sold out since Q2 2024 (13)

Positions held at the end of Q2 2024 that are gone from this filing.

Positions of StemPoint Capital LP sold out since Q2 2024
SecurityClassShares in Q2 2024Value in Q2 2024% of portfolio in Q2 2024History
IMCRImmunocore Holdings plcADS339,351$11.5M3.4%History
MRKMerck & Co., Inc.Stock81,508$10.2M3.0%History
GSKGSK plcADR245,933$9.47M2.8%History
KALVKalVista Pharmaceuticals, Inc.COM736,765$8.68M2.6%History
INSMINSMED IncCOM PAR $.0186,980$5.83M1.7%History
CLDXCelldex Therapeutics, Inc.COM NEW144,467$5.35M1.6%History
LRMRLarimar Therapeutics, Inc.COM704,349$5.11M1.5%History
CRBPCorbus Pharmaceuticals Holdings, Inc.COM NEW101,479$4.59M1.4%History
FULCFulcrum Therapeutics, Inc.COM696,464$4.32M1.3%History
SYRESpyre Therapeutics, Inc.COM NEW150,450$3.54M1.0%History
JSPRJasper Therapeutics, Inc.COM NEW143,775$3.26M1.0%History
BDTXBlack Diamond Therapeutics, Inc.COM674,198$3.14M0.9%History
SLNSilence Therapeutics plcADS124,866$2.37M0.7%History